| Recruiting | Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma NCT04749108 | Institut du Cancer de Montpellier - Val d'Aurelle | Phase 2 / Phase 3 |
| Recruiting | Registry Trial to Evaluate the Safety and Efficacy of Hyperthermia in Locally Advanced Cancers NCT05099809 | Mahatma Gandhi Institute of Medical Sciences | — |
| Terminated | A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic NCT04260802 | Ocellaris Pharma, Inc. | Phase 1 / Phase 2 |
| Active Not Recruiting | Microbiome and Rectal Cancer NCT04223102 | University of South Florida | N/A |
| Active Not Recruiting | Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Ca NCT03743649 | M.D. Anderson Cancer Center | Phase 2 / Phase 3 |
| Active Not Recruiting | Financial Distress in Advanced Cancer Patients NCT04053517 | M.D. Anderson Cancer Center | — |
| Withdrawn | Ride to Care - Quality of Life With Transportation for RT NCT03849742 | University of California, San Francisco | N/A |
| Completed | Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and NCT03856060 | M.D. Anderson Cancer Center | N/A |
| Completed | Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings NCT04186884 | M.D. Anderson Cancer Center | — |
| Unknown | Pancreatic Cancer Malnutrition and Pancreatic Exocrine Insufficiency in the Course of Chemotherapy in Unresect NCT04112836 | Moscow Clinical Scientific Center | — |
| Unknown | Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma NCT03815903 | Barretos Cancer Hospital | Phase 3 |
| Active Not Recruiting | Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer NCT03671226 | M.D. Anderson Cancer Center | N/A |
| Unknown | Chemo-radiotherapy as Main Treatment Strategy for Rectal Cancer. Can we Provide a More Precise and Effective T NCT03619668 | Aalborg University Hospital | — |
| Unknown | Identifying Immune-related Biomarkers to Predict the Efficacy of Cancer Immunotherapy NCT03595813 | Institut Paoli-Calmettes | N/A |
| Terminated | Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer NCT03170115 | Instituto Nacional de Cancer, Brazil | Phase 2 |
| Terminated | A Study of OMP-336B11 in Subjects With Locally Advanced or Metastatic Tumors NCT03295942 | OncoMed Pharmaceuticals, Inc. | Phase 1 |
| Completed | A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumor NCT03238027 | Syndax Pharmaceuticals | Phase 1 |
| Terminated | Genetically Engineered PBMC and PBSC Expressing NY-ESO-1 TCR After a Myeloablative Conditioning Regimen to Tre NCT03240861 | Jonsson Comprehensive Cancer Center | Phase 1 |
| Active Not Recruiting | Haloperidol With or Without Chlorpromazine in Treating Delirium in Patients With Advanced, Metastatic, or Recu NCT03021486 | M.D. Anderson Cancer Center | Phase 2 / Phase 3 |
| Completed | Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors NCT03108131 | M.D. Anderson Cancer Center | Phase 2 |
| Unknown | D1 Versus D2 Lymphadenectomy in High Risk Elderly With Gastric Adenocarcinoma NCT03051152 | Italian Research Group for Gastric Cancer | N/A |
| Terminated | Parenteral Nutrition for Patients Treated for Locally Advanced Inoperable Tumors of the Head and Neck NCT02236936 | Arbeitsgemeinschaft medikamentoese Tumortherapie | Phase 3 |
| Completed | Pre-Test Genetic Education and Remote Genetic Counseling in Communicating Tumor Profiling Results to Patients NCT02823652 | ECOG-ACRIN Cancer Research Group | N/A |
| Completed | Adjuvant Hyperthermic Intraperitoneal Chemotherapy for Locally Advanced Gastric Cancer NCT02672865 | Loma Linda University | Phase 1 |
| Unknown | Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer NCT02404051 | Consorzio Oncotech | Phase 3 |
| Completed | Positron Emission Tomography (PET) During Radio-chemotherapy to Treat Otorhinolaryngological Cancer NCT02469922 | Center Eugene Marquis | N/A |
| Completed | Olaparib and Radiotherapy in Inoperable Breast Cancer NCT02227082 | The Netherlands Cancer Institute | Phase 1 |
| Completed | Healthy Bones Study NCT01973673 | University Health Network, Toronto | N/A |
| Completed | Chemoimmunotherapy and Radiation in Pancreatic Cancer NCT01903083 | Providence Health & Services | Phase 1 |
| Terminated | Immunotherapy Study in Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer NCT01836432 | NewLink Genetics Corporation | Phase 3 |
| Unknown | Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Canc NCT01871363 | Chinese Academy of Medical Sciences | Phase 2 |
| Completed | Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy NCT01847001 | Columbia University | Phase 2 |
| Unknown | Trial of Neoadjuvant Chemotherapy in Locally Advanced Colon Cancer NCT01675999 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Unknown | Metformin Plus Neoadjuvant Chemotherapy in Breast Cancer NCT01566799 | Instituto Nacional de Cancerologia de Mexico | Phase 2 |
| Completed | Neoadjuvant Erbitux Based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer NCT01434394 | Shanghai Jiao Tong University School of Medicine | Phase 2 / Phase 3 |
| Completed | Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix NCT01365156 | M.D. Anderson Cancer Center | Phase 3 |
| Completed | Neo-adjuvant Erbitux-based Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer NCT01440270 | Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Completed | A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors NCT01325558 | Altor BioScience | Phase 1 |
| Completed | Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma NCT01333709 | Institut du Cancer de Montpellier - Val d'Aurelle | Phase 2 |
| Completed | Pre-Operative Or Peri-Operative Dox Regimen In Patients With Locally Advanced Resectable Gastric Cancer NCT01876927 | Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Phase 2 |
| Completed | Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast Cancer NCT01143974 | Chinese Academy of Medical Sciences | Phase 4 |